This trial will collect blood and tumor tissue samples to study circulating tumor DNA, which may be useful for cancer detection, predicting treatment response, and disease monitoring.
1 Primary · 1 Secondary · Reporting Duration: 5 years
40 Total Participants · 1 Treatment Group
Primary Treatment: Archival tumor tissue collection and blood draws · No Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: